USFDA concludes BIMO inspection at Alkem Laboratories’ Bioequivalence Center

13 Mar 2025 Evaluate

U.S Food and Drug Administration (USFDA) has concluded a Bioresearch Monitoring (BIMO) inspection at Alkem Laboratories’ Bioequivalence Center located at Taloja, Maharashtra. The said inspection conducted from March 10, 2025 to March 13, 2025. At the end of the inspection, no Form 483 was issued. 

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.

Alkem Laboratories Share Price

5702.00 90.35 (1.61%)
05-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1521.50
Zydus Lifesciences 933.10
Lupin 2089.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×